Publisher
Springer Berlin Heidelberg
Reference121 articles.
1. Akita S, Akino K, Hirano A, Ohtsuru A, Yamashita S (2010) Noncultured autologous adipose-derived stem cells therapy for chronic radiation injury. Stem Cells Int 2010:532704
2. Argiris A, Karamouzis MV, Gooding WE, Branstetter BF, Zhong S, Raez LE, Savvides P, Romkes M (2011) Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer. J Clin Oncol 29:1140–5
3. Argiris A, Li S, Savvides P, Forastiere AA, Burtness B (2015) Safety analysis of a phase III randomized trial of chemotherapy with or without bevacizumab (B) in recurrent or metastatic squamous cell carcinoma of the head anc neck (R/M SCCHN). ASCO Meet Abstr 33:6022
4. Bernstein JA (2012) Correlation between a pollen challenge chamber and a natural allergen exposure study design for eliciting ocular and nasal symptoms: early evidence supporting a paradigm shift in drug investigation? J Allergy Clin Immunol 130:128–9
5. Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, Redl H, Rubin JP, Yoshimura K, Gimble JM (2013) Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stroma/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 15:641–8